Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-Bone Metastatic Fractures?

Clinical Orthopaedics and Related Research - United States
doi 10.1007/s11999-015-4167-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cardiac Surgery and Allogeneic Blood Transfusions

2012English

Moderate Exposure to Allogeneic Blood Products Is Not Associated With Reduced Long-Term Survival After Surgery for Coronary Artery Disease

Anesthesiology
AnesthesiologyPain Medicine
2009English

Current and Future Alternatives for Allogeneic Blood Product Transfusions

Oncology & Hematology Review (US)
2007English

Mucormycosis Associated With Deferoxamine Therapy After Allogeneic Bone Marrow Transplantation

Cancer Control
MedicineOncologyHematology
1997English

Reactions After Stored Blood Transfusions

BMJ
1942English

Major Postoperative Complications Are Associated With Impaired Long-Term Survival After Upper Abdominal Cancer Surgery: A Complete National Cohort Study

Clinical Nutrition ESPEN
EndocrinologyNutritionMetabolismDieteticsDiabetes
2016English

Pycnodysostosis With Recurrent Long Bone Fractures

International Journal of Research in Orthopaedics
2019English

Treatment Factors Associated With Long-Term Survival After Cytoreductive Surgery and Regional Chemotherapy for Patients With Malignant Peritoneal Mesothelioma

Surgery
Surgery
2013English

Long Bone Metastases as Predictors of Survival in Patients With Metastatic Renal Cancer

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy